SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-15-005350
Filing Date
2015-11-12
Accepted
2015-11-12 16:04:02
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 944496
2 ex10-1.htm EX-10.1 175111
3 ex31-1.htm EX-31.1 12436
4 ex31-2.htm EX-31.2 12361
5 ex32-1.htm EX-32.1 7423
  Complete submission text file 0001493152-15-005350.txt   5439680

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE immy-20150930.xml EX-101.INS 850629
7 XBRL SCHEMA FILE immy-20150930.xsd EX-101.SCH 62633
8 XBRL CALCULATION FILE immy-20150930_cal.xml EX-101.CAL 87909
9 XBRL DEFINITION FILE immy-20150930_def.xml EX-101.DEF 261830
10 XBRL LABEL FILE immy-20150930_lab.xml EX-101.LAB 472392
11 XBRL PRESENTATION FILE immy-20150930_pre.xml EX-101.PRE 361848
Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35814 | Film No.: 151224238
SIC: 2834 Pharmaceutical Preparations